Active Filter(s):
Details:
Adastra's clinical candidate, zotiraciclib, is initially being developed for the treatment of high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG).
Lead Product(s): Zotiraciclib,Temozolomide
Therapeutic Area: Oncology Product Name: TG02
Highest Development Status: Phase I/ Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 28, 2020